Aguilera JT

Idioma: Español
Referencias bibliográficas: 11
Paginas: 101-104
Archivo PDF: 43.19 Kb.

RESUMEN

Las bronquiectasias se consideran un s�ndrome que asocia muchas etiolog�as. Este t�rmino describe la dilataci�n anormal e irreversible y el engrosamiento de la pared del bronquio, causando una inadecuada eliminaci�n y acumulo de moco en las v�as respiratorias, al igual que inflamaci�n e infecci�n microbiana persistente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Beirne PA, Banner NR, Khaghani A, et al. Lung transplantation on noncystic fibrosis bronchiectasis: Analysis of a 13 year experience, J Heart Lung transplant 2005: 24:1530.

2. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008; 14:595-599.

3. Elkins MR, Robinson M, Ross BR, et al. A control trial of lung-term inhaled hypertonic saline in patience with CF. N Engl J Med 2006; 354: 229-240.

4. Flume PA, Yankaskas JR, Eveling M, et al. Massive hemoptysis in CF. Chest 2005; 128:729-738.

5. Horvath I, Loukides S, Wodehouse T, et al. Increase levels of exhales carbon monoxide in bronchiectasis: A new marker of oxidative stress. Thorax 1998; 53:867-860

6. Keane MP, Arenberg DA,Moore BB, et al. CXC chemoqines and angiogenesis/angiostasis. Proc Assoc Am Physicians 1998;110:288- 296.

7. Nicotra MB, Rivera M, Dale AM, et al. Clinical, pathophysiologic, and microbiologic characterization of bronchectasis in an aging cohort. Chest 1995;108:955-961.

8. ODonnell AE. Bronchiectasis. Chest 2008;134:815-823

9. Prikk K, Maici P, Pirila E, et al. Invivo collagenase-2 (MM-8) expression by human bronchial epithelial cells and monocytes/ macrophages in bronchectasis. J Pathol 2001;194:232-238.

10. Rayner CF, Rutman A, Dewar A, et al. Ciliary disorientation in patients with chronic upper respiratory tract inflammation. Am J Respir Crit Care Med 1995;151:800-804.

11. Reid LM. Reduction in brochialsubdivision in bronchiectasis. Thorax 1995;5:233